U.S. markets open in 2 hours 40 minutes

Baxter International Inc. (BAX)

NYSE - NYSE Delayed Price. Currency in USD
55.19-0.81 (-1.45%)
At close: 04:00PM EST
55.01 -0.18 (-0.33%)
After hours: 07:35PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Continuation Wedge (Bearish)

Continuation Wedge (Bearish)

Previous Close56.00
Bid0.00 x 900
Ask0.00 x 900
Day's Range55.02 - 56.03
52 Week Range49.83 - 89.70
Avg. Volume3,849,135
Market Cap27.822B
Beta (5Y Monthly)0.59
PE Ratio (TTM)27.59
Earnings DateN/A
Forward Dividend & Yield1.16 (2.10%)
Ex-Dividend DateDec 01, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-9% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Baxter International Inc.
    Analyst Report: Baxter International Inc.Based in Deerfield, Illinois, Baxter International provides critical care, nutrition, renal, hospital, and surgical products. Baxter has approximately 60,000 employees and manufacturing operations in more than 20 countries. It is also a component of the S&P 500.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Business Wire

    Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference

    DEERFIELD, Ill., November 16, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.

  • Business Wire

    Baxter Declares Quarterly Dividend

    DEERFIELD, Ill., November 15, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 3, 2023, to shareholders of record as of December 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.

  • GlobeNewswire

    Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022

    Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patientsNew ex vivo study demonstrates superior performance of the Theranova dialyzer in effectively balancing higher removal of large middle-molecule toxins and albumin stability during hemodialysis DEERFIELD, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations